Date on Master's Thesis/Doctoral Dissertation
8-2021
Document Type
Master's Thesis
Degree Name
M.S.
Department
Pharmacology and Toxicology
Degree Program
Pharmacology and Toxicology, MS
Committee Chair
Barve, Shirish
Committee Co-Chair (if applicable)
McClain, Craig
Committee Member
McClain, Craig
Committee Member
Ghare, Smita
Committee Member
Gobejishvili, Leila
Committee Member
Hein, David
Author's Keywords
Histone deacetylases; alcohol; Liver; mouse
Abstract
Alcohol abuse is endemic worldwide and there is no FDA approved treatment for Alcohol-Associated Liver Disease (ALD). Many scholars have posited that targeting Histone Deacetylases (HDAC) may be therapeutic in ALD intervention. In this study, the changes in hepatic gene expression and immune phenotyping of mice undergoing chronic plus binge alcohol exposure was examined. The characterization of relative mRNA levels for all 18 HDAC were performed. Results showed decreased expression of the genes HDAC 1,7,9,10,11 and Sirtuin enzymes (SIRT) 3,4,5,7. Other pathways related to lipid metabolism as well as systemic inflammation and hepatic injury also exhibited significant changes. These altered pathways were normalized with the administration of the HDAC inhibitor Trichostatin A (TSA) in primary mouse hepatocytes. These results suggest the potential importance of HDAC dysregulation in ALD mouse models. Future studies should investigate the interactions between HDAC and the molecular mechanisms that control the gut-liver-brain axis.
Recommended Citation
Bodduluri, Srineil, "Histone deacetylases in alcohol associated Liver disease." (2021). Electronic Theses and Dissertations. Paper 3735.
https://doi.org/10.18297/etd/3735